Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question

Lee HW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intrahepatic cholangiocarcinoma arising in Caroli's disease

Jang MH, Lee YJ, Kim H

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cost-of-illness studies: concepts, scopes, and methods

Jo C

Liver diseases are one of the main causes of death, and their ever-increasing prevalence is threatening to cause significant damage both to individuals and society as a whole. This damage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of focal nodular hyperplasia with growth progression during pregnancy

Kim MJ, Han SY, Baek YH, Lee SW, Kwon HJ

Focal nodular hyperplasia (FNH) is the second most common benign solid tumor of the liver and is usually found in young females. In FNH, spontaneous bleeding or rupture rarely occurs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy

Ko SY, Kim BK, Kim DW, Kim JH, Choe WH, Seo HY, Kwon SY

Reversible focal lesions on the splenium of the corpus callosum (SCC) have been reported in patients with mild encephalitis/encephalopathy caused by various infectious agents, such as influenza, mumps, adenovirus, Varicella...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Composite liver tumors: A radiologic-pathologic correlation

Nayyar M, Imagawa DK, Tirkes T, Demirjian , Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C

Bi-phenotypic neoplasm refers to tumors derived from a common cancer stem cell with unique capability to differentiate histologically into two distinct tumor types. Bi-phenotypic hepatocellular carcinoma-cholangiocarcinoma (HCC-CC), although a rare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis

Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW

BACKGROUND/AIMS: Portal-vein thrombosis (PVT) develops in 10-25% of cirrhotic patients and may aggravate portal hypertension. There are few data regarding the effects of anticoagulation on nonmalignant PVT in liver cirrhosis....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of viral hepatitis in liver transplant recipients

Jeong SW, Choi Y, Kim JW

Recurrence of viral hepatitis after liver transplantation (LT) can progress to graft failure and lead to a decrease in long-term survival. Recently, there have been remarkable improvement in the treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection

Cho YK, Kim YN, Song BC

BACKGROUND/AIMS: This study evaluated the predictors of spontaneous viral clearance (SVC), as defined by two consecutive undetectable hepatitis C virus (HCV) RNA tests performed > or =12 weeks apart, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY

BACKGROUND/AIMS: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Song BC, Cho YK, Jwa H, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU

BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Geographic differences in the epidemiological features of HCV infection in Korea

Kim KA, Jeong SH, Jang ES, Kim YS, Lee YJ, Jung EU, Kim IH, Cho SB, Kee MK, Kang C

BACKGROUND/AIMS: The prevalence of hepatitis C virus (HCV) infection in Korea exhibits significant geographic variation, with it being higher in Busan and Jeonam than in other areas. The reason for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Kim JH, Kim JM, Cho YZ, Na JH, Kim HS, Kim HA, Kang HW, Baik SK, Kwon SO, Cha SH, Kim YJ, Kim MY

BACKGROUND/AIMS: Angiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are thought to reduce the dynamic portion of intrahepatic resistance. This study compared the effects of combined treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr